REG - One Health Group PLC - Contract with Hospital renewed on longer terms

One HealthAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260407:nRSG3255Za&default-theme=true

RNS Number : 3255Z  One Health Group PLC  07 April 2026

One Health Group plc

("One Health", the "Company" or the "Group")

 

Contract with Sheffield Teaching Hospital renewed on longer terms

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded
surgical procedures for patients referred by their GP through 'Patient
Choice', announces that it has signed a renewed contract with Sheffield
Teaching Hospital ("STH"), one of the Company's longest standing
commissioners. The multi-million-pound agreement will run for three years,
rather than renewing annually as it has done previously.

 

In April 2024
(https://www.onehealth.co.uk/news/two-major-contracts-renewed-on-significantly-longer-terms?_gl=1*1oghbh4*_up*MQ..*_ga*MjA1NTI0MjU2OC4xNzcxMzM3MTQ2*_ga_KKRGZGH787*czE3NzEzMzcxNDUkbzEkZzEkdDE3NzEzMzcxNjYkajM5JGwwJGgw)
, One Health's two largest commissioners, Lincolnshire Integrated Care Board
("ICB") and South Yorkshire ICB, also renewed their agreements for five years,
rather than renewing annually. The combination of these three contracts, all
renewed on longer terms, represents c.80% of One Health's activity, with the
remaining c.20% representing other direct NHS trusts and non-contract
customers. Negotiating another long-term agreement reinforces confidence in
One Health's model and supports the Company's continued contribution to the
NHS' infrastructure.

 

Adam Binns, Chief Executive Officer, commented:

"We have supported STH for over 10 years and look forward to continuing to do
so during this agreement and beyond. The certainty of these longstanding
contracts with STH, Lincolnshire ICB and South Yorkshire ICB allow us to focus
on our first Surgical Hub, which is currently under construction, and continue
to provide crucial support for the NHS as it faces sustained and ongoing
operational pressure."

 

This announcement contains inside information for the purposes of
the UK Market Abuse Regulation and the Directors of the Company are
responsible for the release of this announcement.

 

If you wish to keep up to date on Company news please email:
onehealth@walbrookpr.com (mailto:onehealth@walbrookpr.com)

 

For more information, please contact:

 

 One Health Group plc                                                                                                www.onehealth.co.uk/investors (http://www.onehealth.co.uk/investors)

 Derek Bickerstaff, Chairman                                                                                         Via Walbrook PR

 Adam Binns, CEO

 Panmure Liberum (Nominated Adviser and Broker)                                                                      Tel: +44 (0)20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

                                             (mailto:onehealth@walbrookpr.com)
 Alice Woodings / Paul McManus /

                                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
 Rachel Broad

                                               +44 (0)7747 515 393

 

About One Health Group plc (www.onehealth.co.uk (http://www.onehealth.co.uk) )

One Health engages 80 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and, in the year, to
March 2025 provided much needed care to 17,020 new patients, through over
42,000 consultations and over 7,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from over 60 NHS commissioning bodies in addition to contracts with
local NHS Hospital Trusts to transfer their internal waiting list patients to
One Health for quicker treatment.

 

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman
and Adam Binns, Chief Executive Officer, which offers insights into the
Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement
(https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTKZGGDKZMGVZM



            Copyright 2019 Regulatory News Service, all rights reserved